BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
BLB Solicitors - The Leading Chronic Pain & CRPS Solicitors
  • Home
  • About Us
    • Andrew Atkinson
    • Bruce Dyer
    • Clare Lowes
    • David Gazzard
    • Mark Tawn
    • Richard Lowes
  • Pain Conditions
    • CRPS Compensation
    • Fibromyalgia Solicitors
    • Myofascial Pain Syndrome Compensation Claim
    • Somatic Symptom Disorder Compensation Claim
    • Neuropathic Pain Compensation Claim
    • Functional Neurological Disorder Compensation
    • Chronic Fatigue Syndrome (ME) Compensation Claim
    • Chronic Pain Syndrome Compensation Claim
  • Unhappy With Your Solicitor?
  • Case Studies
    • Testimonials
  • Blog
  • Contact Us

Home » Research suggests Fibromyalgia is an autoimmune condition

Fibromyalgia Jul 8th, 2021
Writing autoimmune with a marker pen

Research suggests Fibromyalgia is an autoimmune condition

Visit our respected and comprehensive Fibromyalgia and Chronic Pain information hub.

The results of a very promising collaborative study on Fibromyalgia (FM) between King’s College, London (KCL), the University of Liverpool and the Karolinska Institute in Sweden, has been published in The Journal of Clinical Investigation.

People living with Fibromyalgia report a host of symptoms. This research has shown that many of those symptoms, including increased pain sensitivity, reduced movement, muscle weakness, and a reduction in the number of small nerve fibres in the skin, result from antibodies that increase the activity of pain-sensing nerves. This is a particularly important finding as it demonstrates that Fibromyalgia is a disease of the immune system instead of the long-held view that its origin lies in the brain. In so doing, the door may well be open to a host of new therapeutic options.

Pain Research Institute Director, Dr Andreas Goebel, said “When I initiated this study in the UK, I expected that some fibromyalgia cases may be autoimmune. But David Andersson’s [KCL] team have discovered pain-causing antibodies in each recruited patient. The results offer amazing hope that invisible, devastating fibromyalgia symptoms become treatable.”

An important finding was that mice injected with Fibromyalgia antibodies as part of the study subsequently seemed to recover once the antibodies were removed from their system. This suggests existing therapies which reduce levels of antibodies have an excellent prospect of proving effective for Fibromyalgia.

Watch this space…

Richard Lowes
Make an Enquiry

Contact Us

Contact Form

Left Column

Right Column

Centre

 
Sending

Recent Articles

  • Meet your chronic pain solicitor: Andrew Atkinson
  • CRPS on the rise but 62% of the UK have never heard of it
  • New fibromyalgia diagnostic guidelines
  • Could spider venom hold the key to treating chronic pain?
  • Study suggests Botox can prolong the benefit of a nerve block for CRPS

Share this Article

Newsletter Sign-up

* indicates required

Legal Glossary

Find Out More

You may also like...

  • Mar 29th, 2021
    Proving a chronic pain claim Part 2: evidence
    Read Article
  • Aug 26th, 2021
    Chronic pain after COVID-19
    Read Article
View All Related Articles

Get in Touch Today

Contact Form

Left Column

Right Column

Centre

 
Sending

1 Edgar Buildings,
George Street,
Bath, BA1 2DU

01225 462871 01225 445060
Authorised & Regulated by Solicitors Regulation Authority (No. 636644).
©2022 BLB Solicitors  |  Privacy & Terms